Literature DB >> 14730255

Advances in penumbra imaging with MR.

Stephen M Davis1, Geoffrey A Donnan.   

Abstract

The concept of the ischaemic penumbra as critically hypoperfused and functionally impaired, but potentially viable brain, was introduced over 25 years ago. Recent studies have used a combination of perfusion-weighted magnetic resonance imaging (PWI) and diffusion-weighted imaging (DWI) to delineate the putative penumbra. PWI provides semiquantitative cerebral blood flow imaging and DWI is an index of the largely irreversible ischaemic core. PWI > DWI mismatch is an operational definition of the penumbra that was introduced in the late 1990s. This definition has been modified in recent years with the recognition that the PWI boundary includes a region of benign oligaemia and that a portion of the DWI core is potentially salvageable with rapid reperfusion. An MRI penumbral signature is present in the majority of patients within 6 h of stroke onset, often but not invariably associated with proximal arterial occlusion on magnetic resonance angiography, and is strictly time dependent. It has been postulated that penumbral imaging using MRI can provide a physiological 'tissue clock' and be used to predict benefit from thrombolytic therapy beyond the established 3-hour window. This has been suggested by pilot studies, but confirmation will rely on ongoing, prospective, randomized trials. The presence and extent of the penumbra may also predict the opportunity for tissue salvage with neuroprotection strategies. DWI and PWI parameters are being used in proof-of-principle stroke trials. Such trials can be performed with 100-200 patients randomized between treated and control groups and provide a biological signal of efficacy with only 10% of the sample size required for a Phase III study. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730255     DOI: 10.1159/000075301

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  5 in total

1.  Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update.

Authors:  Feng Chen; Yi-Cheng Ni
Journal:  World J Radiol       Date:  2012-03-28

Review 2.  Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment.

Authors:  Beida Ren; Ling Tan; Yuebo Song; Danxi Li; Bingjie Xue; Xinxing Lai; Ying Gao
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

3.  Oxygen metabolism in ischemic stroke using magnetic resonance imaging.

Authors:  Hongyu An; Qingwei Liu; Yasheng Chen; Katie D Vo; Andria L Ford; Jin-Moo Lee; Weili Lin
Journal:  Transl Stroke Res       Date:  2011-12-13       Impact factor: 6.829

4.  Accuracy and reliability assessment of CT and MR perfusion analysis software using a digital phantom.

Authors:  Kohsuke Kudo; Soren Christensen; Makoto Sasaki; Leif Østergaard; Hiroki Shirato; Kuniaki Ogasawara; Max Wintermark; Steven Warach
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

5.  Imaging Oxygen Metabolism In Acute Stroke Using MRI.

Authors:  Hongyu An; Andria L Ford; Katie D Vo; Qingwei Liu; Yasheng Chen; Jin-Moo Lee; Weili Lin
Journal:  Curr Radiol Rep       Date:  2014-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.